These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 14722278
1. A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions. Derdowski A, Ding L, Spearman P. J Virol; 2004 Feb; 78(3):1230-42. PubMed ID: 14722278 [Abstract] [Full Text] [Related]
2. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag). Sandefur S, Smith RM, Varthakavi V, Spearman P. J Virol; 2000 Aug; 74(16):7238-49. PubMed ID: 10906178 [Abstract] [Full Text] [Related]
3. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain. Accola MA, Strack B, Göttlinger HG. J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843 [Abstract] [Full Text] [Related]
4. The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag. Sandefur S, Varthakavi V, Spearman P. J Virol; 1998 Apr; 72(4):2723-32. PubMed ID: 9525590 [Abstract] [Full Text] [Related]
5. Direct measurement of Gag-Gag interaction during retrovirus assembly with FRET and fluorescence correlation spectroscopy. Larson DR, Ma YM, Vogt VM, Webb WW. J Cell Biol; 2003 Sep 29; 162(7):1233-44. PubMed ID: 14517204 [Abstract] [Full Text] [Related]
6. The host protein Staufen1 participates in human immunodeficiency virus type 1 assembly in live cells by influencing pr55Gag multimerization. Chatel-Chaix L, Abrahamyan L, Fréchina C, Mouland AJ, DesGroseillers L. J Virol; 2007 Jun 29; 81(12):6216-30. PubMed ID: 17428849 [Abstract] [Full Text] [Related]
7. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). VerPlank L, Bouamr F, LaGrassa TJ, Agresta B, Kikonyogo A, Leis J, Carter CA. Proc Natl Acad Sci U S A; 2001 Jul 03; 98(14):7724-9. PubMed ID: 11427703 [Abstract] [Full Text] [Related]
8. Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation. Joshi A, Nagashima K, Freed EO. J Virol; 2006 Aug 03; 80(16):7939-51. PubMed ID: 16873251 [Abstract] [Full Text] [Related]
9. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. Spearman P, Wang JJ, Vander Heyden N, Ratner L. J Virol; 1994 May 03; 68(5):3232-42. PubMed ID: 8151785 [Abstract] [Full Text] [Related]
10. HIV-1 Vpr Abrogates the Effect of TSG101 Overexpression to Support Virus Release. Chutiwitoonchai N, Siarot L, Takeda E, Shioda T, Ueda M, Aida Y. PLoS One; 2016 May 03; 11(9):e0163100. PubMed ID: 27648839 [Abstract] [Full Text] [Related]
11. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins. Huvent I, Hong SS, Fournier C, Gay B, Tournier J, Carrière C, Courcoul M, Vigne R, Spire B, Boulanger P. J Gen Virol; 1998 May 03; 79 ( Pt 5)():1069-81. PubMed ID: 9603321 [Abstract] [Full Text] [Related]
12. Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release. Goff A, Ehrlich LS, Cohen SN, Carter CA. J Virol; 2003 Sep 03; 77(17):9173-82. PubMed ID: 12915533 [Abstract] [Full Text] [Related]
13. Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles. Chatel-Chaix L, Clément JF, Martel C, Bériault V, Gatignol A, DesGroseillers L, Mouland AJ. Mol Cell Biol; 2004 Apr 03; 24(7):2637-48. PubMed ID: 15024055 [Abstract] [Full Text] [Related]
14. Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100. Holm K, Weclewicz K, Hewson R, Suomalainen M. J Virol; 2003 Apr 03; 77(8):4805-17. PubMed ID: 12663787 [Abstract] [Full Text] [Related]
15. Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag. Harila K, Prior I, Sjöberg M, Salminen A, Hinkula J, Suomalainen M. J Virol; 2006 Apr 03; 80(8):3765-72. PubMed ID: 16571793 [Abstract] [Full Text] [Related]
16. Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding. Ono A, Demirov D, Freed EO. J Virol; 2000 Jun 03; 74(11):5142-50. PubMed ID: 10799589 [Abstract] [Full Text] [Related]
17. Defects in human immunodeficiency virus budding and endosomal sorting induced by TSG101 overexpression. Goila-Gaur R, Demirov DG, Orenstein JM, Ono A, Freed EO. J Virol; 2003 Jun 03; 77(11):6507-19. PubMed ID: 12743307 [Abstract] [Full Text] [Related]
18. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Martin-Serrano J, Zang T, Bieniasz PD. Nat Med; 2001 Dec 03; 7(12):1313-9. PubMed ID: 11726971 [Abstract] [Full Text] [Related]
19. Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding. Hogue IB, Hoppe A, Ono A. J Virol; 2009 Jul 03; 83(14):7322-36. PubMed ID: 19403686 [Abstract] [Full Text] [Related]
20. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. Müller B, Daecke J, Fackler OT, Dittmar MT, Zentgraf H, Kräusslich HG. J Virol; 2004 Oct 03; 78(19):10803-13. PubMed ID: 15367647 [Abstract] [Full Text] [Related] Page: [Next] [New Search]